Ani Pharmaceuticals, Inc. <ANIP.O>: Guggenheim Cuts Target Price to $119 From $124
ANIP•Related News
Silexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers
SLXN•
Duke Energy Corp <DUK.N>: Jefferies cuts target price to $129 from $136
DUK•
Ipsos-IWSR whitepaper commissioned by AB InBev flags moderation as key alcohol consumption trend
BUD•
Silence Therapeutics to discuss Phase 2 SANRECO trial topline results for divesiran in polycythemia vera
SLN•
Agilon Health, Inc. <AGL.N>: TD Cowen Raises Target Price to $95 From $55
AGL•